Your browser doesn't support javascript.
loading
HPLC method development for the simultaneous analysis of amlodipine and valsartan in combined dosage forms and in vitro dissolution studies
Çelebier, Mustafa; Kaynak, Mustafa Sinan; Altınõz, Sacide; Sahin, Selma.
  • Çelebier, Mustafa; Hacettepe University. Faculty of Pharmacy. Department of Analytical Chemistry. Ankara. TR
  • Kaynak, Mustafa Sinan; Hacettepe University. Faculty of Pharmacy. Department of Pharmaceutical Technology. Ankara. TR
  • Altınõz, Sacide; Hacettepe University. Faculty of Pharmacy. Department of Analytical Chemistry. Ankara. TR
  • Sahin, Selma; Hacettepe University. Faculty of Pharmacy. Department of Pharmaceutical Technology. Ankara. TR
Braz. j. pharm. sci ; 46(4): 761-768, Oct.-Dec. 2010. ilus, graf, tab
Article in English | LILACS | ID: lil-622876
ABSTRACT
A simple, rapid and reproducible HPLC method was developed for the simultaneous determination of amlodipine and valsartan in their combined dosage forms, and for drug dissolution studies. A C18 column (ODS 2, 10 μm, 200 x 4.6 mm) and a mobile phase of phosphate buffer (pH 3.6 , 0.01 mol L-1)acetonitrile methanol (464410 v/v/v) mixture were used for separation and quantification. Analyses were run at a flow-rate of 1 mL min-1 and at ambient temperature. The injection volume was 20 μL and the ultraviolet detector was set at 240 nm. Under these conditions, amlodipine and valsartan were eluted at 7.1 min and 3.4 min, respectively. Total run time was shorter than 9 min. The developed method was validated according to the literature and found to be linear within the range 0.1 - 50 μg mL-1 for amlodipine, and 0.05 - 50 μg mL-1 for valsartan. The developed method was applied successfully for quality control assay of amlodipine and valsartan in their combination drug product and in vitro dissolution studies.
RESUMO
Desenvolveu-se método de HPLC rápido e reprodutível para a determinação simultânea de anlodipino e valsartana em suas formas de associação e para os estudos de dissolução dos fármacos. Utilizaram-se coluna C18 (ODS 2, 10 μm, 200 x 4,6 mm) e fase móvel tampão fosfato (pH 3,6, 0,01 mol L-1)acetonitrila metanol para a separação e a quantificação. As análises foram efetuadas com velocidade de fluxo de 1 mL min-1 e à temparatura ambiente O volume de injeção foi de 20 μL e utilizou-se detector de ultravioleta a 240 nm. Sob essas condições, anlodipino e valsartana foram eluídas a 7,1 min e 3,4 min, respectivamente. O tempo total de corrida foi menor que 9 min. O método desenvolvido foi validado de acordo com a literatura e se mostrou linear na faixa de 0,1-50 μg mL-1 para anlodipino e de 0,05-50 μg mL-1 para valsartana. O método desenvolvido foi aplicado com sucesso para ensaios de controle de qualidade de associações de anlodipino e valsartana e nos estudos de dissolução in vitro.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: In Vitro Techniques / Cardiovascular Agents / Chromatography, High Pressure Liquid / Dissolution / Antihypertensive Agents Type of study: Practice guideline Language: English Journal: Braz. j. pharm. sci Year: 2010 Type: Article Affiliation country: Turkey Institution/Affiliation country: Hacettepe University/TR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: In Vitro Techniques / Cardiovascular Agents / Chromatography, High Pressure Liquid / Dissolution / Antihypertensive Agents Type of study: Practice guideline Language: English Journal: Braz. j. pharm. sci Year: 2010 Type: Article Affiliation country: Turkey Institution/Affiliation country: Hacettepe University/TR